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O’Sullivan and colleagues showed a marked increase in test
usage in primary care.1 This has implications not only for general
practitioner workload, but also for clinicians interpreting test
results. Despite rising testing rates we are not seeing a
concomitant rise in disease incidence. Presumably testing is
shifting into populations at lower risk of disease.
But tests work in a bayesian fashion, meaning that interpretation
depends on two things—the performance characteristics of the
test itself and the subgroup of people it is performed on (the
prior odds or pretest probability of disease).
This can have counter intuitive implications; we have shown,
for example, that people with normal test results have an
increased risk of cancer.2 3 This is because merely conducting
a test predicts cancer, and this additional risk is only partly
eliminated by a negative test result.
O’Sullivan and colleagues’ work, however, suggests dilution of
this effect. As we increase testing rates in lower risk populations,
the opposite problem may occur—people with positive test
results will have a lower incidence of disease. This will lead to
a reduction in the signal-to-noise ratio, lower positive predictive
values, and more false positives.
In other words, the more tests we do, the less we can trust the
results.
We need better evidence, not only on the diagnostic accuracy
of tests but on whom to test in the first place and, perhaps just
as importantly, whom not to test.
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